Ipsapirone in the treatment of bulimia nervosa: An open pilot study
β Scribed by Geretsegger, Christian ;Greimel, Karoline V. ;Roed, Llona S. ;Hesselink, Jan M. Keppel
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1995
- Tongue
- English
- Weight
- 326 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0276-3478
No coin nor oath required. For personal study only.
β¦ Synopsis
Seventeen women who met the criteria for bulimia nervosa (DSM-Ill-R) were treated for 4 weeks in an open trial with ipsapirone, a partial 5-HT,* agonist. Bulimic symptoms diminished in 66.6% of the patients after only 7 week of treatment, 93.3% showed a reduction of more than 50% of weekly binge eating attacks after 4 weeks. The mean frequency of binges was reduced by81% at endpoint. lpsapirone was well tolerated. 0
π SIMILAR VOLUMES
Objective: To examine the rates of exclusion and inclusion in various research studies for a series of 51 treatment-seeking patients. Method: The inclusion and exclusion criteria employed in a sample of 41 studies were applied to a series of 51 treatment-seeking bulimia nervosa patients. Results: Of
## Objective: To determine whether a graded exercise program used in the treatment of anorexia nervosa improves quality of life and does not decrease the rate of gain of body fat. ## Methods: A randomized controlled trial with outcome measures: change in percent body fat, body mass index (bmi), a